In the Media
February 17, 2026
FDA go-ahead to test cellular rejuvenation therapy in humans
Nature Biotechnology
January 31, 2026
2026 Age Reversal: 5 Real Innovations To Stop Us Growing Old
Longevity Science News
January 30, 2026
As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
Fortune
January 28, 2026
FDA clears first human trial of epigenetic reprogramming therapy
Longevity.Technology
January 27, 2026
Exclusive: In major test for longevity field, FDA greenlights study on a ‘near total reset’ of cells
Endpoints News
December 31, 2025
This new drug may have cracked the ‘cheat code’ for reversing ageing
BBC Science Focus
October 30, 2025
This Longevity Startup Is Bringing Anti-Aging Gene Therapy to Human Trials
New York Observer
August 27, 2025
ARDD 2025: Hitting rewind, not reset, for in vivo rejuvenation | BioWorld
BioWorld
August 26, 2025
Life Bio: epigenetic rejuvenation ‘transcends organs’
Longevity.Technology
August 14, 2025
Conversations from the Front Lines of Drug Development with Jerry McLaughlin, CEO of Life Biosciences
The Few & Far Between Podcast
July 24, 2025
Life Biosciences announces collaboration in Singapore to expand pipeline of cellular rejuvenation therapies
BioSpectrum Asia
June 13, 2025
Scientists are turning back the clock
Genetic Engineering & Biotechnology News
June 4, 2025
Partial epigenetic reprogramming: the “holy grail” for aging therapeutics
Translating Aging Podcast
April 22, 2025
Changing Perceptions of Aging with Michael Ringel
Longevity Dialogues Podcast
March 27, 2025
EP 24: Michael Ringel, PhD, Life Biosciences
A4Li H-SPAN Podcast
March 11, 2025
The Scientific Search for Youth
TIME
March 6, 2025
Can reprogramming our genes make us young again?
The Washington Post
February 12, 2025
The Science, Evolution, and Future of Lifespan and Healthspan with Dr. Michael Ringel
Longevity by Design Podcast
January 1, 2025
The Multifaceted Future of Pharma. Exploring Therapeutic Areas Shaping the Future of Drug Development
The Medicine Maker
December 9, 2024
Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics John Maslowski
Business of Biotech Podcast
October 29, 2024
Life Biosciences Is Bringing Reprogramming to the Clinic
Lifespan.io
October 23, 2024
The top 10 takeaways from AAO 2024
Ophthalmology Times
October 22, 2024
Life Biosciences Presents New Data on Epigenetic Reprogramming for Optic Neuropathies at AAO 2024
Biopharma Trend
October 22, 2024
Life Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual function
Ophthalmology Times
October 8, 2024
BostInno’s 2024 Fire Awards honorees
BOSTINNO, Boston Business Journal
October 3, 2024
To Reverse Aging’s Clock, Adjust the Cell’s Machinery
Genetic Engineering & Biotechnology News
September 12, 2024
Partial epigenetic reprogramming to treat ischemic optic neuropathy
BioWorld
August 29, 2024
S2 Ep12 – Jerry McLaughlin
The BioHub Podcast
August 27, 2024
Tapping into the ‘tremendous potential’ of cellular rejuvenation
Longevity.Technology
August 5, 2024
Interview with Sponsors at ARDD 2024: Life Biosciences Sharon Rosenzweig-Lipson, PhD
ARDD YouTube
July 25, 2024
Innovating Approaches to Target Diseases of Aging with Jerry McLaughlin, CEO of Life Biosciences
Xtalks Podcast
June 25, 2024
Sharon Rosenzweig-Lipson, Chief Scientific Officer at Life Biosciences
HER SCRIPT Podcast
April 10, 2024
Epigenetic Technologies Find Clinical Applications
Genetic Engineering & Biotechnology News
March 12, 2024
The twelve hottest biotech companies in the Boston area
Labiotech.eu
March 14, 2024
Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences Sharon Rosenzweig-Lipson PhD
Cell & Gene Podcast
January 8, 2024
The science of ageing and restoring healthspan
Drug Target Review
November 29, 2023
Longevity summit hears how we could all be living longer
The National
November 20, 2023
Jerry McLaughlin – Chief Executive Officer and Board Member – Life Biosciences, Inc.
Progress, Potential, and Possibilities Podcast
October 31, 2023
‘Breakthroughs in labs are translating to breakthroughs in medicine’
Longevity Technology
October 17, 2023
Companies Seek To Increase Life Span By A Decade Or More
Forbes
September 14, 2023
Bio & The Business Of Aging With Life Biosciences Jerry McLaughlin
Business of Biotech Podcast
August 2, 2023
Life Biosciences Grows Up: A Q&A With Jerry McLaughlin
Life Science Leader
June 19, 2023
Pioneering Gene Therapy Restores Vision in Primates
Ophthalmology Breaking News
May 15, 2023
Life Biosciences, Forge Biologics Partner for Manufacturing to Advance Gene Therapies
BioPharm International
May 10, 2023
Cellular rejuvenation: a new era in age-related disease treatment
Labiotech
April 28, 2023
OSK-driven epigenetic reprogramming restores visual function in nonhuman primates
BioWorld
April 25, 2023
Glimpse of success? Life Biosciences’ gene therapy restores visual function in primates with eye disorder
Fierce Biotech
January 23, 2023
Epigenetic Manipulations Can Accelerate or Reverse Aging in Mice
The Scientist
December 2, 2020
Genetic reprogramming rejuvenates nerve cells and restores vision in mice
STAT News
December 2, 2020
Reversing vision loss by turning back the aging clock
Fierce Biotech